How Much Is Your Life Worth? Defining What The Willingness To Pay For A QALY Is and Should Be

October 18, 2018 Danielle Twigg

Many countries have a national Health Technology Assessment (HTA) body that makes decisions/recommendations on publically reimbursing new healthcare technologies. For some, a key criterion is cost-effectiveness based upon their cost per Quality Adjusted Life Year (QALY) in relation to willingness to pay (WTP) thresholds. This research aims to identify, compare and evaluate WTP thresholds across countries.

Authors: Hristina Ivanova, James Campbell, Cornelia Roibu, Richard Macaulay

To find out more about this poster you can register to download it here after the ISPOR event.

Previous Article
Medicinrådet And The New Hospital Drug Appraisal Process In Denmark – The Story So Far
Medicinrådet And The New Hospital Drug Appraisal Process In Denmark – The Story So Far

Next Article
Exploring The Impact Of Radiographic Progressive Disease And First Subsequent Therapy On Health State Utility Values
Exploring The Impact Of Radiographic Progressive Disease And First Subsequent Therapy On Health State Utility Values